| DNA methylation inhibitors in cancer: recent and future approaches C Gros, J Fahy, L Halby, I Dufau, A Erdmann, JM Gregoire, F Ausseil, ... Biochimie 94 (11), 2280-2296, 2012 | 283 | 2012 |
| Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells S Valente, Y Liu, M Schnekenburger, C Zwergel, S Cosconati, C Gros, ... Journal of medicinal chemistry 57 (3), 701-713, 2014 | 131 | 2014 |
| New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors C Gros, L Fleury, V Nahoum, C Faux, S Valente, D Labella, F Cantagrel, ... Journal of Biological Chemistry 290 (10), 6293-6302, 2015 | 69 | 2015 |
| Design, Synthesis and Biological Evaluation of 4‐Amino‐N‐(4‐aminophenyl)benzamide Analogues of Quinoline‐Based SGI‐1027 as Inhibitors of DNA Methylation E Rilova, A Erdmann, C Gros, V Masson, Y Aussagues, ... ChemMedChem 9 (3), 590-601, 2014 | 66 | 2014 |
| Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity D Rotili, D Tarantino, B Marrocco, C Gros, V Masson, V Poughon, ... PLoS One 9 (5), e96941, 2014 | 45 | 2014 |
| Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies C Gros, L Chauvigne, A Poulet, Y Menon, F Ausseil, I Dufau, PB Arimondo Nucleic acids research 41 (19), e185-e185, 2013 | 45 | 2013 |
| Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells C Zwergel, M Schnekenburger, F Sarno, C Battistelli, MC Manara, G Stazi, ... Clinical epigenetics 11, 1-18, 2019 | 35 | 2019 |
| Preparation of phenylethylbenzamide derivatives as modulators of DNMT3 activity A Kabro, H Lachance, I Marcoux-Archambault, V Perrier, V Doré, C Gros, ... MedChemComm 4 (12), 1562-1570, 2013 | 28 | 2013 |
| Design and synthesis of new non nucleoside inhibitors of DNMT3A A Erdmann, Y Menon, C Gros, N Molinier, N Novosad, A Samson, ... Bioorganic & Medicinal Chemistry 23 (17), 5946-5953, 2015 | 27 | 2015 |
| A Direct Fluorescent Activity Assay for Glycosyltransferases Enables Convenient High‐Throughput Screening: Application to O‐GlcNAc Transferase MG Alteen, C Gros, RW Meek, DA Cardoso, JA Busmann, G Sangouard, ... Angewandte Chemie International Edition 59 (24), 9601-9609, 2020 | 26 | 2020 |
| Identification and optimization of hydrazone-gallate derivatives as specific inhibitors of DNA methyltransferase 3A A Erdmann, Y Menon, C Gros, V Masson, Y Aussagues, F Ausseil, ... Future Medicinal Chemistry 8 (4), 373-380, 2016 | 16 | 2016 |
| Quantifying lysosomal glycosidase activity within cells using bis-acetal substrates S Cecioni, RA Ashmus, PA Gilormini, S Zhu, X Chen, X Shan, C Gros, ... Nature Chemical Biology 18 (3), 332-341, 2022 | 15 | 2022 |
| A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells MC Deen, Y Zhu, C Gros, N Na, PA Gilormini, DL Shen, S Bhosale, ... Proceedings of the National Academy of Sciences 119 (29), e2200553119, 2022 | 14 | 2022 |
| Side‐Chain Effects on the 1‐(Bis‐aryl‐methylidene)‐[3] ferrocenophane Skeleton: Antiproliferative Activity against TNBC Cancer Cells and Comparison with the Acyclic Ferrocifen … M Gormen, P Pigeon, Y Wang, A Vessières, S Top, F Martial, C Gros, ... European Journal of Inorganic Chemistry 2017 (2), 454-465, 2017 | 7 | 2017 |
| Synthèse et caractérisation de nouveaux inhibiteurs de la méthylation de l'ADN dans les cancers C Gros Toulouse 3, 2014 | | 2014 |
| Angewandte DJ Vocadlo, MG Alteen, C Gros, R Meek, DA Cardoso, J Busmann, ... | | |
